Showing results (151-160 of 222) with videos related to
Sort By:
Pageof 23
Acta Psychiatrica Scandinavica|March 11, 2004
Does nicotine affect D2 receptor upregulation? A case-control studyS Silvestri, J C Negrete, M V Seeman, et al.Journal of Medicinal Chemistry|December 1, 1991
(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationshipJ L Neumeyer, N Baindur, H B Niznik, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1985
Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2H B Niznik, D E Grigoriadis, I Pri-Bar, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1987
Response of tardive and L-dopa-induced dyskinesias to antidepressantsM el-Awar, M Freedman, P Seeman, et al.Neuroscience Letters|April 19, 1985
Dopamine D2 receptors photolabeled by iodo-azido-cleboprideH B Niznik, A Dumbrille-Ross, J H Guan, et al.Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.Journal of Medicinal Chemistry|February 1, 1990
Development of a high affinity and stereoselective photoaffinity label for the D-1 dopamine receptor: synthesis and resolution of 7-[125I]iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5-tetrahydro- 1H-3-benzazepineJ L Neumeyer, N Baindur, J Yuan, et al.Psychiatry Research|December 1, 1984
Total and free plasma neuroleptic levels in schizophrenic patientsS W Tang, J Glaister, L Davidson, et al.Clinical Genetics|February 5, 2011
High frequency of SH3TC2 mutations in Czech HMSN I patientsP Laššuthová, R Mazanec, P Vondráček, et al.Scientific Reports|April 20, 2021
Biallelic variants in the SORD gene are one of the most common causes of hereditary neuropathy among Czech patientsP Laššuthová, R Mazanec, D Staněk, et al.Pageof 23